BIO.NRW-Newsticker
Aktuelles aus Wirtschaft und Wissenschaft
Aktuelle Unternehmensmitteilungen aus NRW
03.05.12
Qiagen Acquires AmniSure International
Qiagen N.V.. (5/3/12). "Press Release: Qiagen Acquires AmniSure International to Add Unique Assay to Emerging Point of Need Portfolio". Hilden & Germantown, MD.
> QIAGEN expands Point of Need portfolio with unique AmniSure® assay to detect rupture of fetal membranes (ROM) - checked in up to 30% of U.S. pregnancies
> Novel FDA-cleared test is highly synergistic with QIAGEN's clinical sales channels
QI... [more]
02.05.12
Molecular Devices to Attend European Lab Automation
Molecular Devices, LLC. (5/2/12). "Press Release: Molecular Devices to Attend European Lab Automation. Hamburg, Germany 30th–31st May 2012".
Molecular Devices will be showcasing their ImageXpress® Micro XL and SpectraMax Paradigm during European Lab Automation, at the Congress Centre Hamburg in Hamburg, Germany, 30-31 May 2012.
ImageXpress® Micro XL is an invaluable tool for pinpointi... [more]
30.04.12
Cardinal Health to Offer Qiagen MDx Procucts to US Hospitals
Qiagen N.V.. (4/30/12). "Press Release: Qiagen and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals. Collaboration Creates Distribution Channel to Previously Underserved Market Segment". Germantown
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that Cardinal Health (NYSE: CAH) has extended its portfolio of laboratory offerings to select U.S. hospitals to include QIAGEN automated laboratory systems and test kits for mo... [more]
27.04.12
Bayer Board Chairman Speaks at Annual Stockholders’ Meeting
Bayer AG. (4/27/12). "Press Release: Management Board Chairman Dr. Marijn Dekkers at the Annual Stockholders’ Meeting of Bayer AG. Bayer Has Great Potential for the Future Too". Leverkusen.
Fiscal 2011 was strategically and operationally successful / Proposal to raise the dividend for 2011 to EUR 1.65 per share / Encouraging start to 2012 / Good progress with the development of innovative products / Werner Wenning to become Chairman of ... [more]
25.04.12
Qiagen Announces Organisational and Leadership Changes
Qiagen N.V.. (4/25/12). "Press Release: Qiagen Makes Organizational and Leadership Changes (AD HOC Announcement According to §15 WpHG)". Venlo.
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that it was making organizational changes designed to capture opportunities and further improve its capabilities to address the needs of its customers.
Two new Business Area... [more]
